{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:24:49Z","timestamp":1792113889134,"version":"4.4.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Diffuse intrinsic pontine gliomas are lethal tumors with a prognosis generally less than 1 year. Few cases of survivors of 5 years or more have been reported. This case report highlights the journey of a 9.5-year survivor who underwent 3 rounds of focal radiotherapy; she experienced 6 years of progression-free survival following the first round but ultimately succumbed to her disease. An autopsy revealed a favorable IDH1 mutation and the absence of H3K27M. This case reiterates the importance of extensive molecular analyses in diffuse intrinsic pontine gliomas and explores the potential benefit of re-irradiation in patients with positive responses and long periods of remission.<\/jats:p>","DOI":"10.1097\/mph.0000000000002853","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T10:00:10Z","timestamp":1712224810000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature"],"prefix":"10.1097","volume":"46","author":[{"given":"Evan","family":"Dimentberg","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Laval"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pier","family":"Marceau","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Laval"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lachance","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universit\u00e9 Laval"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bergeron-Gravel","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Saikali","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical Biology, and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Crevier","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bourget","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hemato-Oncology, CHU de Qu\u00e9bec-Universit\u00e9 Laval, Quebec"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Jabado","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology \u2013 Neuropathology, The Hospital for Sick Children, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Giannakouros","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hemato-Oncology, Montreal Children\u2019s Hospital, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Renzi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hemato-Oncology, Montreal Children\u2019s Hospital, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Larouche","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hemato-Oncology, Montreal Children\u2019s Hospital, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"e26751","DOI":"10.1002\/pbc.26751","article-title":"Molecular Alterations in Pediatric Brainstem Gliomas","volume":"65","author":"Porkholm","year":"2018","journal-title":"PEDIATR Blood Cancer"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/a-1849-1478","article-title":"Dipg- very Long-term Survivors - are There Factors Which May Predict a Better Outcome?","volume":"234","author":"Stock","year":"2022","journal-title":"Klin Padiatr"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: Critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"343","DOI":"10.21037\/tcr.2019.03.12","article-title":"Long-term survivors of diffuse intrinsic pontine glioma (dipg): Myth or reality","volume":"2","author":"Carceller","year":"2019","journal-title":"Transl Cancer Res"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41016-020-00218-w","article-title":"Diffuse intrinsic pontine glioma: Current insights and future directions","volume":"7","author":"Srikanthan","year":"2021","journal-title":"Chin Neurosurg j"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/neuonc\/noab140","article-title":"Characteristics of patients \u226510 years of age with diffuse intrinsic pontine glioma: A report from the international dipg\/dmg Registry","volume":"24","author":"Erker","year":"2022","journal-title":"Neuro Oncol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11060-020-03568-8","article-title":"Pontine Gliomas a 10-year Population-based study: a Report From the Canadian Paediatric Brain Tumour Consortium (cpbtc)","volume":"149","author":"Fonseca","year":"2020","journal-title":"J Neurooncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nou104","article-title":"Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria","volume":"17","author":"Jansen","year":"2015","journal-title":"Neuro Oncol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (dipg): A collaborative report from the International and European Society for Pediatric Oncology Dipg Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-017-2702-7","article-title":"Diffuse intrinsic pontine gliomas (dipg) at recurrence: Is there a window to test new therapies in some patients?","volume":"137","author":"Lobon-iglesias","year":"2018","journal-title":"J Neurooncol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"k27m mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"khuong-quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/neuonc\/noac123","article-title":"Characteristics of children \u226436 months of age with dipg: A report from the International Dipg Registry","volume":"24","author":"Bartlett","year":"2022","journal-title":"Neuro Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-013-1189-0","article-title":"Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma","volume":"114","author":"Jackson","year":"2013","journal-title":"J Neurooncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/08465371221109921","article-title":"Radiomic features based on MRI predict progression-free survival in pediatric diffuse midline glioma\/diffuse intrinsic pontine glioma","volume":"74","author":"Wagner","year":"2023","journal-title":"Can Assoc Radiol j"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3174\/ajnr.A3421","article-title":"Mr imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"34","author":"Sedlacik","year":"2013","journal-title":"Ajnr Am j Neuroradiol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/neuonc\/noaa140","article-title":"Mr imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: Report From the International Dipg Registry","volume":"22","author":"Leach","year":"2020","journal-title":"Neuro Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3171\/2008.11.PEDS08281","article-title":"Treatment of diffuse intrinsic brainstem gliomas: Failed approaches and future strategies","volume":"3","author":"Frazier","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00381-019-04363-1","article-title":"Clinical trials for diffuse intrinsic pontine glioma: The Current State of Affairs","volume":"36","author":"Rechberger","year":"2020","journal-title":"Childs Nerv syst"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3171\/2022.2.JNS211920","article-title":"Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients","volume":"137","author":"Wang","year":"2022","journal-title":"J Neurosurg"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-010-0224-7","article-title":"POST mortem examinations in diffuse intrinsic pontine glioma: Challenges and chances","volume":"101","author":"Angelini","year":"2011","journal-title":"J Neurooncol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.21.02839","article-title":"Postmortem tissue donation: Giving families the ability to choose","volume":"41","author":"Frenkel","year":"2023","journal-title":"J Clin Oncol"},{"key":"R22-20250804","first-page":"vdac100","article-title":"Does a bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review","volume":"4","author":"Evans","year":"2022","journal-title":"Neurooncol adv"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:00:14Z","timestamp":1754337614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002853","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"2023-11-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}